CERo Therapeutics Holdings, Inc. (NASDAQ:CERO – Get Free Report) major shareholder Bioventures Opportunities G. Yk sold 2,998,908 shares of the firm’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $0.06, for a total transaction of $179,934.48. Following the transaction, the insider now directly owns 13,005,169 shares in the company, valued at $780,310.14. The trade was a 18.74 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
CERo Therapeutics Trading Down 18.5 %
NASDAQ:CERO traded down $0.01 on Friday, hitting $0.06. The stock had a trading volume of 31,185,395 shares, compared to its average volume of 20,494,506. CERo Therapeutics Holdings, Inc. has a 1 year low of $0.06 and a 1 year high of $12.80. The firm’s fifty day simple moving average is $0.13 and its two-hundred day simple moving average is $0.22.
CERo Therapeutics Company Profile
Featured Stories
- Five stocks we like better than CERo Therapeutics
- Buy P&G Now, Before It Sets A New All-Time High
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- What Are Earnings Reports?
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for CERo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CERo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.